Destiny Pharma PLC
LSE:DEST
Destiny Pharma PLC
LSE:DEST
Price:
18.25 GBX
2.82%
Market Closed
Updated:
May 2, 2024
Destiny Pharma PLC
Cash from Investing Activities
|
Destiny Pharma PLC
Cash from Investing Activities Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Destiny Pharma PLC
LSE:DEST
|
Cash from Investing Activities
£77.7k
|
CAGR 3-Years
-73%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Cash from Investing Activities
-$127m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Cash from Investing Activities
-$11m
|
CAGR 3-Years
9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Cash from Investing Activities
-$2.9m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Cash from Investing Activities
-£5.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Cash from Investing Activities
-£21.4m
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
6%
|
See Also
What is Destiny Pharma PLC's Cash from Investing Activities?
Cash from Investing Activities
77.7k
GBP
77.7k
GBP
Based on the financial report for Jun 30, 2023, Destiny Pharma PLC's Cash from Investing Activities amounts to 77.7k GBP.
What is Destiny Pharma PLC's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
-73%
-73%
Over the last year, the Cash from Investing Activities growth was 275%. The average annual Cash from Investing Activities growth rates for Destiny Pharma PLC have been -73% over the past three years .
You don't have any saved screeners yet
